Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1397 |
---|---|
Product Name | Anti-Human CD115 Recombinant Antibody(Cabiralizumab) |
Molecular Name | Cabiralizumab |
Alias | Anti-CD115 Recombinant Antibody, Research Grade Cabiralizumab |
CAS Number | 1613144-80-1 |
Target | CD115[Homo sapiens] |
Isotype | IgG4 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | ELISA, IHC, IF, IP, FCM, Inhib |
Buffer | PBS, pH7.5 |
Background | CSF1R inhibitionitors have been developed as a potential route to reduce the presence of TAMs in the tumor microenvironment. As of 2017, CSF1R inhibitionitors that are currently in early stage clinical trials include Pexidartinib, PLX7486, ARRY-382, JNJ-40346527, BLZ945, Emactuzumab, AMG820, IMC-CS4, MCS110, and Cabiralizumab. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |